☆ 4.6 Article

CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection

EUROPEAN JOURNAL OF PEDIATRICS (2023)

Related references

Note: Only part of the references are listed.
Article Hematology

Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH

Arianna De Matteis et al.

Summary: The activation profile of CD8(+) T cells can distinguish different types of HLH patients and those with early sepsis. The frequency of CD4(dim)CD8(+) T cells is correlated with the severity of MAS.

BLOOD (2022)

Add to Collection
Article Hematology

T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis

Vandana Chaturvedi et al.

Summary: Hemophagocytic lymphohistiocytosis (HLH) is characterized by acute T-cell activation, with CD38(high)/HLA-DR+ effector cells being most pronounced. In contrast, sepsis does not show this distinctive T-cell activation. CD38(high)/HLA-DR+ cells concentration above 7% has strong predictive value for distinguishing HLH from early sepsis or healthy controls.

BLOOD (2021)

Add to Collection
Article Infectious Diseases

Clinical and laboratory characteristics of hemophagocytic lymphohistiocytosis induced by Leishmania infantum infection

Qi Shi et al.

Summary: The study found significant differences in clinical and laboratory characteristics between patients with VL associated HLH and those with VL only, including higher inflammation status, higher parasite load, and higher risk of complications in VL associated HLH patients.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Add to Collection
Article Immunology

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN WITH VISCERAL LEISHMANIASIS

Daniel Blazquez-Gamero et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)

Add to Collection
Review Oncology

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

Jan-Inge Henter et al.

PEDIATRIC BLOOD & CANCER (2007)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.